CLINICAL ROLE -
Cost of Squamous Cell Cancer of the Head and Neck
The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia
Study assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.
2 Commerce Drive Cranbury, NJ 08512